Caveolin-1 as a potential high-risk prostate cancer biomarker

Author：                        

Publisher： Spandidos Publications

ISSN： 1021-335X

Source： Oncology Reports, Vol.27, Iss.3, 2012-01, pp. : 831-841

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The high-risk prostate cancer patient

By Hussain M.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 3, 2003-05 ,pp. : 211-211

Elsevier

Access to resources Recommend Favorite

Treatment for intermediate and high-risk prostate cancer: Controversial issues and the role of hyperthermia

By Maluta Sergio   Dall'oglio Stefano   Nadalini Luisa  

International Journal of Hyperthermia, Vol. 26, Iss. 8, 2010-12 ,pp. : 765-774

Informa Healthcare

Access to resources Recommend Favorite

High-risk localized prostate cancer: primary surgery and adjuvant therapy

By Skinner E.C.   Glode L.M.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 3, 2003-05 ,pp. : 219-227

Elsevier

Access to resources Recommend Favorite

High-risk prostate cancer: the role of radical prostatectomy for local therapy

By Ghavamian Reza   Williams Steve K   Hakimi A Ari  

Future Oncology, Vol. 7, Iss. 4, 2011-04 ,pp. : 543-550

Future Medicine

Access to resources Recommend Favorite

Metastasis-related Genes in Prostate Cancer: The Role of Caveolin-1

By Thompson T.C.  

Cancer and Metastasis Reviews, Vol. 17, Iss. 4, 1998-01 ,pp. : 439-442

Springer Publishing Company

Access to resources Recommend Favorite